First batch of Sputnik V vaccine delivered to Mexico
MOSCOW, Feb. 23, 2021 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces the delivery of the first batch of Sputnik V vaccine against coronavirus to Mexico.
On February 3, 2021 the Federal Commission for the Protection against Sanitary Risk of Mexico (COFEPRIS) approved Sputnik V under the emergency use authorization procedure without additional clinical trials in the country. Mexico has become the first country of North America to approve Sputnik V.
Sputnik V is approved for use in more than 30 countries making the vaccine one of the world's top three coronavirus vaccines in terms of the number of approvals issued by regulatory authorities.
Russia, Belarus, Argentina, Bolivia, Serbia, Algeria, Palestine, Venezuela, Paraguay, Turkmenistan, Hungary, UAE, Iran, Republic of Guinea, Tunisia, Armenia, Mexico, Nicaragua, Republika Srpska (entity of Bosnia and Herzegovina), Lebanon, Myanmar, Pakistan, Mongolia, Bahrain, Montenegro, Saint Vincent and the Grenadines, Kazakhstan, Uzbekistan, Gabon, San Marino and Ghana have authorized Sputnik V.
Kirill Dmitriev, CEO of the Russian Direct Investment Fund, commented:
"RDIF supports the efforts of the Government of Mexico to protect the population with a safe and effective Russian Sputnik V vaccine. Cooperation between Russia and Mexico on the vaccine is a great example of pooling efforts to jointly fight the pandemic and save lives. The positive decision of COFEPRIS to grant an emergency use authorization to Sputnik V provides people of Mexico with access to one of the best vaccines in the world."
Sputnik V has a number of key advantages:
Efficacy of Sputnik V is 91.6% as confirmed by the data published in the Lancet, one of the world's oldest and most respected medical journals; It is one of only three vaccines in the world with efficacy of over 90%; Sputnik V provides full protection against severe cases of COVID-19.
The Sputnik V vaccine is based on a proven and well-studied platform of human adenoviral vectors, which cause the common cold and have been around for thousands of years.
Sputnik V uses two different vectors for the two shots in a course of vaccination, providing immunity with a longer duration than vaccines using the same delivery mechanism for both shots.
The safety, efficacy and lack of negative long-term effects of adenoviral vaccines have been proven by more than 250 clinical studies over two decades.
The developers of the Sputnik V vaccine are working collaboratively with AstraZeneca on a joint clinical trial to improve the efficacy of AstraZeneca vaccine.
There are no strong allergies caused by Sputnik V.
The price of Sputnik V is less than $10 per shot, making it affordable around the world.
Russian Direct Investment Fund (RDIF) is Russia's sovereign wealth fund established in 2011 to make equity co-investments, primarily in Russia, alongside reputable international financial and strategic investors. RDIF acts as a catalyst for direct investment in the Russian economy. RDIF's management company is based in Moscow. Currently, RDIF has experience of the successful joint implementation of more than 80 projects with foreign partners totaling more than RUB2 tn and covering 95% of the regions of the Russian Federation. RDIF portfolio companies employ more than 800,000 people and generate revenues which equate to more than 6% of Russia's GDP. RDIF has established joint strategic partnerships with leading international co-investors from more than 18 countries that total more than $40 bn. Further information can be found at rdif.ru
Sky Harbour Group Corporation ("SHG" or the "Company"), an aviation infrastructure company building the first nationwide network of Home-Basing campuses for business aircraft, today announced that it will release its First Quarter 2024 financial...
Victoria Gold Corp. ("Victoria" or the "Company") held its Annual General Meeting (the "Meeting") earlier today, May 10, 2024, in Vancouver, British Columbia. Shareholders voted in favour of all items proposed by the board of directors and...
Canada Jetlines Operations Ltd. (Cboe CA:CJET) ("Canada Jetlines" or the "Company"), one of Canada's leading leisure airlines, today reported financial results for the first quarter ended March 31, 2024. All financial figures are...
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class Period") of the important June 11, 2024 lead...
Applied DNA Sciences, Inc. ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced consolidated financial results for its second fiscal quarter ended March 31, 2024. The Company's Form 10-Q can...
Striking new work from the acclaimed visual artist behind the Covid flags on the Mall opened to the public today at Freedom Plaza in Washington, D.C. Suzanne Brennan Firstenberg launched her latest work "alienable right to life," at a moving opening...